Article
Ophthalmologists are always looking to broaden their procedure offerings to increase their revenue stream.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Q&A: Michael Lai, MD, PhD, on the impact of underfunding the Good Days program
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Bascom Palmer Eye Institute ranked as top ophthalmology hospital in US for 22nd year in a row
(EyePod) From idea to impact: Navigating ophthalmic innovation
Navigate successful cataract surgery with refractive technology
Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38%